Market Overview - The medical services sector increased by 2.17% on November 13, with Chengda Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Top Gainers in Medical Services - Chengda Pharmaceutical (301201) closed at 41.00, up 14.21% with a trading volume of 168,000 shares and a transaction value of 650 million [1] - Digital Human (920670) closed at 18.16, up 5.70% with a trading volume of 114,000 shares [1] - Mucai Pharmaceutical (600721) closed at 9.59, up 4.92% with a trading volume of 338,800 shares [1] - Other notable gainers include ST Zhongzhu (600568) and Haoyuan Pharmaceutical (688131) with increases of 4.81% and 4.59% respectively [1] Market Capital Flow - The medical services sector saw a net inflow of 454 million from institutional investors, while retail investors experienced a net outflow of approximately 20.9 million [2] - The overall trend indicates a strong interest from institutional investors despite the outflow from retail investors [2] Individual Stock Performance - WuXi AppTec (603259) had a significant net inflow of 590 million, representing 11.01% of its trading volume, while it faced a net outflow of 361 million from speculative funds [3] - Other companies like Kanglong Chemical (300759) and Baihua Pharmaceutical (600721) also showed mixed capital flows, with institutional inflows but outflows from speculative and retail investors [3]
医疗服务板块11月13日涨2.17%,诚达药业领涨,主力资金净流入4.54亿元